Book chapter · 2023

Human iPS Cells for Clinical Applications and Cellular Products

Moyra Lawrence

Handbook of experimental pharmacology, 281, 3–27 · Published 25 March 2023 · DOI 10.1007/164_2023_643

View at the publisherCite this paper

In brief

“Human iPS Cells for Clinical Applications and Cellular Products” is a 2023 book chapter by Moyra Lawrence, published in Handbook of experimental pharmacology. OpenAlex counts 3 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
3
Most cited in
2023 (2)
Field-weighted impact
1.19
References
104
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lawrence, M. (2023). Human iPS Cells for Clinical Applications and Cellular Products. Handbook of experimental pharmacology, 281, 3–27. https://doi.org/10.1007/164_2023_643

MLA 9

Lawrence, Moyra. “Human iPS Cells for Clinical Applications and Cellular Products.” Handbook of experimental pharmacology, vol. 281, 2023, pp. 3–27. https://doi.org/10.1007/164_2023_643.

Chicago

Lawrence, Moyra. 2023. “Human iPS Cells for Clinical Applications and Cellular Products.” Handbook of experimental pharmacology 281: 3–27. https://doi.org/10.1007/164_2023_643.

Harvard

Lawrence, M. (2023) ‘Human iPS Cells for Clinical Applications and Cellular Products’, Handbook of experimental pharmacology, 281, pp. 3–27. doi:10.1007/164_2023_643.

IEEE

M. Lawrence, “Human iPS Cells for Clinical Applications and Cellular Products,” Handbook of experimental pharmacology, vol. 281, pp. 3–27, 2023, doi: 10.1007/164_2023_643.

BibTeX

@incollection{lawrence2023human,
  title     = {{Human iPS Cells for Clinical Applications and Cellular Products}},
  author    = {Lawrence, Moyra},
  booktitle = {Handbook of experimental pharmacology},
  publisher = {Springer Science+Business Media},
  year      = {2023},
  volume    = {281},
  pages     = {3--27},
  doi       = {10.1007/164_2023_643},
  url       = {https://doi.org/10.1007/164_2023_643}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • human induced pluripotent stem cells
  • cell therapy manufacturing
  • quality control
  • good manufacturing practices
  • iPSC differentiation
  • clinical trials
  • cell therapy
  • genome editing

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Lawrence, M. (2023). Human iPS Cells for Clinical Applications and Cellular Products. Handbook of experimental pharmacology, 281, 3–27. https://doi.org/10.1007/164_2023_643

How many times has this paper been cited?

3 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Moyra Lawrence.

What is the DOI of this paper?

10.1007/164_2023_643, permanently at https://doi.org/10.1007/164_2023_643. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.